RecruitingPhase 2NCT06989359
Renal
Immunoglobulin A nephropathy
94
studies recruiting now
as of 7 Sept 2026
425
studies registered in total
as of 7 Sept 2026
29
countries with a recruiting site
as of 7 Sept 2026
3 Jun 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingPhase 2NCT07522099
Chinese Adults With Kidney Disease
RecruitingPhase 4NCT07604311
Efficacy and Safety of Nefecon on Prevention of Relapse of IgA Nephropathy
RecruitingPhase 3NCT06935357
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
RecruitingPhase 1NCT07623369
A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 94 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Immunoglobulin A nephropathy study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Immunoglobulin A nephropathy
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
3 approved treatments and 38 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: Budesonide (Aircort)Approved: Sparsentan (Filspari)Approved: Iptacopan Hydrochloride (Fabhalta)
Phase 3Iptacopan
Phase 3Icosapent
Phase 3Sibeprenlimab
Phase 3Cyclophosphamide (Cyclophosphamide)
Phase 3Finerenone (Kerendia)
Phase 3Methylprednisolone (Medrol)
Phase 3Losartan
Phase 3Sefaxersen
+ 30 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).